Impact of primary tumour location and RAS/BRAF mutational status in metastatic colorectal cancer treated with first-line regimens containing oxaliplatin and bevacizumab: Prognostic factors from the AIO KRK0207 first-line and maintenance therapy trial
-
Published:2018-09
Issue:
Volume:101
Page:105-113
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Hegewisch-Becker Susanna,
Nöpel-Dünnebacke Stefanie,
Hinke AxelORCID,
Graeven Ullrich,
Reinacher-Schick Anke,
Hertel Jan,
Lerchenmüller Christian A.,
Killing Birgitta,
Depenbusch Reinhard,
Al-Batran Salah-Eddin,
Lange Thoralf,
Dietrich Georg,
Tannapfel Andrea,
Arnold Dirk
Funder
Roche Pharma AG
AIO Studien gGmbH
Subject
Cancer Research,Oncology
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献